Chemoinformaics analysis of D-(+)-Beta-3,4-Dihydrophenyl-Lactic-Acid
Molecular Weight | 168.192 | nRot | 3 |
Heavy Atom Molecular Weight | 156.096 | nRig | 9 |
Exact Molecular Weight | 168.079 | nRing | 1 |
Solubility: LogS | -0.634 | nHRing | 0 |
Solubility: LogP | 0.839 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 25.4375 |
nHD | 2 | BPOL | 12.9065 |
QED | 0.502 |
Synth | 2.707 |
Natural Product Likeliness | 0.217 |
NR-PPAR-gamma | 0.019 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.013 |
Pgp-sub | 0.001 |
HIA | 0.025 |
CACO-2 | -4.77 |
MDCK | 0.0000295 |
BBB | 0.075 |
PPB | 0.872959 |
VDSS | 0.281 |
FU | 0.0904872 |
CYP1A2-inh | 0.253 |
CYP1A2-sub | 0.165 |
CYP2c19-inh | 0.078 |
CYP2c19-sub | 0.063 |
CYP2c9-inh | 0.2 |
CYP2c9-sub | 0.616 |
CYP2d6-inh | 0.139 |
CYP2d6-sub | 0.327 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.114 |
CL | 1.069 |
T12 | 0.851 |
hERG | 0.015 |
Ames | 0.342 |
ROA | 0.043 |
SkinSen | 0.922 |
Carcinogencity | 0.73 |
EI | 0.992 |
Respiratory | 0.624 |
NR-Aromatase | 0.02 |
Antiviral | No |
Prediction | 0.936883 |